Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.36 |
| ▸ | CCR1 | P32246 | 4/20 | 0.33 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.33 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.32 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14720966 | 1.00 | HRH3 (0.36) | HRH3CCR1SRD5A2L3MBTL3L3MBTL1 | |
| SCHEMBL14720603 | 1.00 | HRH3 (0.36) | HRH3CCR1SRD5A2L3MBTL3L3MBTL1 | |
| SCHEMBL14720813 | 0.98 | HRH3 (0.36) | HRH3CCR1SRD5A2L3MBTL3L3MBTL1 | |
| SCHEMBL14721107 | 0.98 | HRH3 (0.36) | HRH3CCR1SRD5A2L3MBTL3L3MBTL1 | |
| SCHEMBL14720811 | 0.98 | HRH3 (0.36) | HRH3CCR1SRD5A2L3MBTL3L3MBTL1 | |
| SCHEMBL14720746 | 0.96 | HRH3 (0.38) | HRH3CCR1OPRL1SLC18A3 | |
| SCHEMBL14720847 | 0.94 | HRH3 (0.38) | HRH3CCR1SRD5A2OPRL1SLC18A3 | |
| SCHEMBL14720807 | 0.93 | HRH3 (0.36) | HRH3CCR1OPRL1SLC18A3 | |
| SCHEMBL14720770 | 0.90 | HRH3 (0.34) | HRH3CCR1SRD5A2OPRL1SLC18A3 | |
| SCHEMBL14721332 | 0.87 | HRH3 (0.39) | HRH3CCR1SRD5A2OPRL1SLC18A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | claimed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |